The 2010 Accelrys UGM will be held May 4-6 in Boston, MA. More information can be found at: http://accelrys.com/events/ugms/2010/us/abstracts.html.

“We chose to integrate with Pipeline Pilot specifically because we feel it is one of the best ways to handle the volume and sequential processing needs of our gene expression content,” said Peter Dresslar, Torrey Path Founder and CEO. “We think the future is bright for biodata and bioinformatics solutions built on the Pipeline Pilot platform, because trends in the industry make the platform increasingly appropriate for biological research computing.”

“Torrey Path is using Pipeline Pilot in exciting new ways to make gene expression data more accessible to life scientists of all kinds,” said Frank Brown, Vice President and Chief Science Officer of Accelrys. “We are pleased to have them join the community of Pipeline Pilot developers.”

Torrey Path has already developed a solution for integrating and reporting on customers’ in-house gene expression data called Gene Expression Reports for Pipeline Pilot. This solution includes statistical pre-processing and characterization with key related biological terminology. Gene Expression Reports for Pipeline Pilot can also be used to work with and integrate the expert-curated gene expression data from existing Torrey Path Content Packs.

Information about the Accelrys ISV program can be found at: http://accelrys.com/company/strategic-alliances/independent-software-vendors.html.

Torrey Path also announced today that Dr. Sirimon O-Charoen, Senior Research Scientist, will present at Accelrys’ European User Group Conference. Dr. O-Charoen will discuss findings in eye disease made analyzing Torrey Path’s Eye Content Pack and using Pipeline Pilot. “Using Pipeline Pilot to Mine Value-added Data from Public Gene Expression Repositories” will be held as part of the conference’s Biology Track on Thursday, October 15th, 2009.

About Torrey Path:
Torrey Path is reinventing the biodata supply chain. By assembling, harmonizing, and delivering biological and biomedical data with an innovative processing pipeline, Torrey Path publishes information for researchers in life sciences industries and institutions that can spark new insight and speed discovery. Torrey Path also provides biodata supply chain integration services for interfacing biological data with custom and third-party software, building knowledge-rich computational environments that are both flexible and economically sustainable.

At Torrey Path, a dominant feature that we see in our industry is the scale of the data involved. Most disciplines in life sciences are highly observational, and there is a lot to observe. Established scanning technologies, such as gene expression microarrays, can easily generate gigabytes of data, and new technologies like next-generation sequencing or functional MRI can produce data on the terabyte scale and beyond. Great new analytics are being developed and applied to making sense of all of the data being produced; some of them locally in San Diego. However, due to the scale and complexity of the data being generated, we continue to see a growing disconnection between the data analyses and the life sciences researchers who are trying to use these data to generate new knowledge. That’s where Torrey Path comes in.

Torrey Path is focused on assembling experimental biological data along with basic, supporting knowledge, and then running biostatistical analyses in bulk across all of the data. Processing just a few experiments this way can take days, so for many analytical techniques it makes economic sense to do it only once at our data center, rather than having our customers do that processing repeatedly and on an ad hoc basis. Other techniques might be more sensitive to end-user input, but even in these cases our customers can benefit from knowing what experiments and what samples might make the most sense to start with. We’ve invested heavily in the processing pipeline, making it so we can add new types of data and new analytical techniques at various points in the process.

The quantity of data we are handling turns out to have not just a numerical effect on the processor times and storage capacities, but an even stronger, qualitative effect on the value chain of analytics and transforming raw data into consumable, sustainable knowledge resources.

Under the terms of the agreement, the partners will cooperate to develop technologies that extend the biodata products and services of Torrey Path, including Torrey Path’s Content Packs and its upcoming release of the VivoConnect data delivery service.

Also as a result of the agreement, Mr. John McNeil will fill the role of Chief Technology Officer at Torrey Path. Mr. McNeil has worked for over twenty years various IT leadership roles in pharmaceutical, biotechnology, and other high-tech industries. Prior to forming and serving as McNeil & Company’s President, Mr. McNeil co-founded the Ibis Division of Isis Pharmaceuticals where he lead government business development and product management. He had previously created the bioinformatics department at Isis and served as V.P. of Informatics and a corporate officer. He had previously worked at SAIC, where he founded the Laboratory Sensors and Automation Division.

“This is a great relationship for Torrey Path and its customers,” said Peter Dresslar, Founder and CEO of Torrey Path, “since it not only strengthens our technical capabilities for development and integration projects, but also allows us to rapidly marshal consulting resources for customers seeking biodata integration at the enterprise level. It also allows us to supply new data capabilities for LabSynch. Customers using our combined solutions will be able to manage, integrate, and explore their experimental data from the lab bench all the way to the boardroom.”

“We are looking forward to developing some great new technologies for publishing and delivering experimental information together with Torrey Path,” said McNeil, “and we expect great benefits for our LabSynch customers in the future as well.”

“Using Pipeline Pilot to Mine Value-added Data from Public Gene Expression Repositories” will be delivered as part of the conference’s Biology Track on Thursday, October 15th, 2009. More information about the conference, including the speaker schedule, can be found at the Accelrys EUGM conference website.

Additionally, Mr. Milton will present “Enter Inner Space” in conjunction with the PDB-CAVE Calit2. PDB-CAVE is a virtual reality tour that explores everything from a Nobel prize winning model of a gene in action to the inner workings of an HIV drug. Billions of dollars in scientific data and state-of-the-art computer visualization technology come together to show atoms and molecules like never before.

Torrey Path will be presenting at Booth #545. More information about the San Diego Science Festival can be found at the website: www.sdsciencefestival.com.

The New Enterprise Forum (NEF) is a not-for-profit corporation founded in 1986 to help entrepreneurs prosper and grow. Since its founding, NEF has been a model for similar groups and a magnet for entrepreneurs and investors throughout Michigan and the Midwest. Its website can be accessed at www.newenterpriseforum.org.

“Our previous Content Packs have already realized rapid uptake in the pharmaceutical industry, and we’re excited to bring these new products to market,” said CEO, Peter Dresslar. “The Content Packs have been very popular for us, as they give our customers direct access to the knowledge locked within gene expression data in ways that weren’t sustainable or even available before.”

Senior Research Scientist Dr. Sirimon O-Charoen added, “As we expand, we are applying deeper and more formal methods for analysis and quality control. Our process includes a proprietary in-house application for content development, which allows us to curate the information much more efficiently.”

Metabolic Content Pack, Cardiovascular Content Pack, and Neurology Content Pack will be released in the second and third quarters of 2009. Torrey Path’s Eye Content Pack was released earlier in 2008 and was immediately recognized as a game-changing tool for scientists and clinicians in ophthalmology. The previously-announced Immunology Content Pack is under development now. All Content Packs will work within the customer’s environment when loaded onto Torrey Path’s Core Platform software.

About Torrey Path:

Torrey Path is a provider of software solutions for scientific computing in life sciences, making biodata easier to assemble, manage, and access. Its patent-pending innovations in data pre-processing and delivery allow Torrey Path to deliver rich, dynamic life sciences data applications to customers in drug discovery and development. With the VivoConnect subscription service, Torrey Path’s Core Platform server is always kept up-to-date with the latest information, creating tremendous efficiencies for customer IT organizations. Torrey Path also generates specialty data packs for individual areas of science, such as Eye and Immunology Content Packs. Founded in 2007, Torrey Path is based in La Jolla, California with offices in Ann Arbor, Michigan. For more information, visit www.torreypath.com or call (+1) 858.456.5900.